Design and evaluation of inhalable chitosan-modified poly (dl-lactic-co-glycolic acid) nanocomposite particles

European Journal of Pharmaceutical Sciences

Volumn 47, Issue 1, 2012, Pages 235-243

  Yang, Mingshi ^a,c   Yamamoto, Hiromitsu ^a,d   Kurashima, Homare ^a   Takeuchi, Hirofumi ^a   Yokoyama, Toyokazu ^b   Tsujimoto, Hiroyuki ^b   Kawashima, Yoshiaki ^a,c  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b Hosokawa Powder Technology Research Institute   (Japan)

^c AICHI GAKUIN UNIVERSITY   (Japan)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Chitosan; Inhalation; Nanocomposite particles; Poly (dl lactic co glycolic acid); Salmon calcitonin

Indexed keywords

CHITOSAN; NANOCOMPOSITE; POLYGLACTIN; SALCATONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOTECHNOLOGICAL PROCEDURES; COMPARATIVE STUDY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG GRANULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOCALCEMIA; LUNG ALVEOLUS EPITHELIUM; LUNG CLEARANCE; LUNG DISTRIBUTION; LUNG FUNCTION; MALE; NANOEMULSION; NONHUMAN; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; SYNTHESIS;

ABSORPTION; ADMINISTRATION, INHALATION; ANIMALS; CALCITONIN; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; HYPOCALCEMIA; LACTIC ACID; LUNG; MALE; NANOCOMPOSITES; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; POWDERS; RATS; RATS, WISTAR; TECHNOLOGY, PHARMACEUTICAL;

EID: 84863492324     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.05.016     Document Type: Article

References (24)

1. H.O. Alpar, S. Somavarapu, K.N. Atuah, and V.W. Bramwell Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery Adv. Drug Deliv. Rev. 57 2005 411 430
2. M. Amidi, E. Mastrobattista, W. Jiskoot, and W.E. Hennink Chitosan-based delivery systems for protein therapeutics and antigens Adv. Drug Deliv. Rev. 62 2010 59 82
3. F. Andrade, M. Videira, D. Ferreira, and B. Sarmento Nanocarriers for pulmonary administration of peptides and therapeutic proteins Nanomedicine 6 2011 123 141
4. R.P. Bagwe, L.R. Hilliard, and W. Tan Surface modification of silica nanoparticles to reduce aggregation and non-specific binding Langmuir 25 2006 4357 4362
5. P.R. Byron, and J.S. Patton Drug delivery via the respiratory tract J. Aerosol. Med. 7 1994 49 75
6. S. Calis, R. Jeyanthi, T. Tsai, R.C. Mehta, and P.P. DeLuca Adsorption of salmon calcitonin to PLGA microspheres Pharm. Res. 12 1995 1072 1076
7. A. Grenha, B. Seijo, and C. Renunan-Lopez Microencapuslated chitosan nanoparticles for lung protein delivery Eur. J. Pharm. Sci. 25 2005 427 437
8. A. Hussain, J.J. Arnold, M.A. Khan, and F. Ahsan Absorption enhancers in pulmonary protein delivery J. Controlled Release. 94 2004 15 24
9. L. Illum Chitosan and its use as a pharmaceutical excipient Pharm. Res. 15 1998 1326 1331
10. Y. Kawashima, H. Yamamoto, H. Takeuchi, T. Hino, and T. Niwa Properties of a peptide containing dl-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods Eur. J. Pharm. Biopharm. 45 1998 41 48
11. K.C. Lee, Y.J. Lee, H.M. Song, C.J. Chun, and P.P. Luca Degradation of synthetic salmon calcitonin in aqueous solution Pharm. Res. 9 1992 1521 1523
12. H.L. Luessen Multifunctional Polymers for Peroral Peptide Drug Absorption 1996 Labor Vincit Leiden
13. E. Rytting, J. Nguyen, X. Wang, and T. Kissel Biodegradable polymeric nanocarriers for pulmonary drug delivery Exp. Opin. Drug Deliv. 5 2008 629 639
14. G. Scheuch, M.J. Kohlhaeufl, P. Brand, and R. Siekmeier Clinical perspectives on pulmonary systemic and macromolecular delivery Adv. Drug Deliv. Rev. 58 2006 996 1008
15. H. Takeuchi, H. Yamamoto, and Y. Kawashima Mucoadhesive nanoparticulate systems for peptide drug delivery Adv. Drug Deliv. Rev. 47 2001 39 54
16. R.N. Tharanathan, and F.S. Kittur Chitin-the undisputed biomolecule of great potential Crit. Rev. Food Sci. Nutr. 43 2003 61 87
17. J.G. Weers, J. Bell, H.K. Chan, D. Cipolla, C. Dunbar, A.J. Hickey, and I.J. Smith Pulmonary formulations: what remains to be done? J. Aerosol. Med. Pulm. D. 23 2010 S5 S23
18. Yang, M., Yamamoto, H., Takeuchi, H., Kawashima, Y., 2004. Nanocomposite particle of salmon calcitonin loaded PLGA nanospheres for dry powder inhalation. In: The 21th symposium on particulate preparations and designs. Otsu, Japan. pp. 237-240.
19. M. Yang, H. Yamamoto, H. Kurashima, H. Takeuchi, and Y. Kawashima In vitro and in vivo inhalation characterization of pH-dependent HP-55 nanospheres containing salmon calcitonin Asian J. Pharm. Sci. 2 2007 1 10
20. M. Yang, H. Yamamoto, H. Kurashima, H. Takeuchi, T. Yokoyama, H. Tsujimoto, and Y. Kawashima Design and evaluation of poly(dl-lactic-co-glycolic acid) nanocomposite particles containing salmon calcitonin for inhalation Eur. J. Pharm. Sci. 2012 10.1016/j.ejps.2012.02.024
21. A. Yamamoto, T. Fujita, and S. Muranishi Pulmonary absorption enhancement of peptides by absorption enhancers and protease inhibitors J. Controlled Release. 41 1996 57 67
22. H. Yamamoto, H. Kurashima, D. Katagiri, M. Yang, H. Takeuchi, Y. Kawashima, T. Yokoyama, and H. Tsujimoto Poly(lactic-co-glycolic acid) nanosphere composite prepared with Mechanofusion dry powder composition system for improving pulmonary insulin delivery with dry powder inhalation J. Pharm. Sci. Technol. 64 2004 245 253
23. H. Yamamoto, Y. Kuno, S. Sugimoto, H. Takeuchi, and Y. Kawashima Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions J. Controlled Release. 102 2005 373 381
24. H. Yamamoto, W. Hoshina, H. Kurashima, H. Takeuchi, Y. Kawashima, T. Yokoyama, and H. Tsujimoto Engineering of poly(dl-lactic-co-glycolic acid) nanocomposite particles for dry powder inhalation dosage forms of insulin with the spray-fluidized bed granulating system Adv. Powder Technol. 18 2007 215 228